Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Reformulated Bivalent Oral Cholera Vaccine in Vietnamese Adults
NCT00128011Phase 2Completed
- Sponsor
- International Vaccine Institute
- Start
- May 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Killed bivalent (O1 and O139) whole cell oral cholera vaccine in cholera, sponsored by International Vaccine Institute. Started May 2005; status: completed.
02
Drugs
Killed bivalent (O1 and O139) whole cell oral cholera vaccine
03
Conditions
cholera
Beyond the preview
Go deeper on NCT00128011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128011.